Evaluation of CAMS versus TAU with suicidal patients - An inpatient RCT CAMS = Collaborative Assessment and Management of Suicidality

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00013727

Enrollment

Registered

2018-01-12

Start date

2017-03-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicidal patients with various underlying diseases F30-F39 F40-F48 F60-F69

Interventions

Group 1: Collaborative Assessment and Management of Suicidality (CAMS) in the context of individual therapeutic consultations (CAMS + SIC) (SIC = Standard Inpatient Care). The inpatient treatment time

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: acute suicidal thoughts or actions (within the last 7 days) largely fluent German language Agreement to participate

Exclusion criteria

Exclusion criteria: - chronic suicidal patients (for our study defined as: within the last 12 months in total more than 12 weeks of in-patient treatment or inpatient treatment in the last 12 months more than 6 admissions) - lawful accommodation based on Psych-KG or BGB (German Civil Code) - currently psychotic symptoms (also in the context of a depressive illness) and patients who have suffered from psychosis within the last 12 months - Eating disorder with BMI < 16 - current substance dependency (substance abuse and previous substance dependency are no exclusion criteria!) - patients with diagnosed reduced intelligence - patients who receive inpatient integration assistance, i. e. live in assisted residential care - Patients with an organically caused mental illness - planned inpatient or partial inpatient treatment immediately afterwards - patients who are already aware that they will only stay for a very short time for crisis intervention (study patients must have at least 10 days of inpatient treatment to ensure that the treatment can be carried out to a sufficient extent)

Design outcomes

Primary

Measure	Time frame
Change in suicidal tendencies measured with the Beck Scale for Suicide Ideation (BSS). The assessment is carried out at the time of admission (pre), on discharge from treatment (post), 4 weeks after treatment (FU-1) and 5 months after treatment (FU-2). We also assess suicidal behavior by self-report.	—

Secondary

Measure	Time frame
Changes in the extent of depressiveness (BDI-II) and general symptom burden (SCL-18-Mini), indication of reasons for life (Brief-RFL-I), evaluation of the therapeutic relationship (D-STAR-P) and satisfaction with inpatient crisis treatment (own questionnaire). The assessment is carried out at the time of admission (pre), on discharge from treatment (post), 4 weeks after treatment (FU-1) and 5 months after treatment (FU-2).	—

Measure

Time frame

Changes in the extent of depressiveness (BDI-II) and general symptom burden (SCL-18-Mini), indication of reasons for life (Brief-RFL-I), evaluation of the therapeutic relationship (D-STAR-P) and satisfaction with inpatient crisis treatment (own questionnaire). The assessment is carried out at the time of admission (pre), on discharge from treatment (post), 4 weeks after treatment (FU-1) and 5 months after treatment (FU-2).

—

Countries

Germany

Contacts

Public ContactMiriam Santel

Evangelisches Klinikum Bethel, Klinik für Psychiatrie und Psychotherapie

Miriam.Santel@evkb.de0521-772-78618

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 27, 2026